Role of hypothalamic de novo ceramides synthesis in obesity and associated metabolic disorders
Background: Sphingolipid-mediated signalling pathways are described as important players in the normal functioning of neurons and nonneuronal cells in the central nervous system (CNS). Scope of review: This review aims to show role of de novo ceramide synthesis in the CNS in controling key physiolog...
Main Authors: | Christophe Magnan, Hervé Le Stunff |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | Molecular Metabolism |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877821001435 |
Similar Items
-
Brain Ceramide Metabolism in the Control of Energy Balance
by: Céline Cruciani-Guglielmacci, et al.
Published: (2017-10-01) -
Ceramides: focus on obesity
by: Yulia A. Dyleva, et al.
Published: (2020-12-01) -
The Impact of Phytochemicals in Obesity-Related Metabolic Diseases: Focus on Ceramide Metabolism
by: Eunkyeong Kim, et al.
Published: (2023-01-01) -
Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
by: Patrycja Bielawiec, et al.
Published: (2020-08-01) -
Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases
by: Suryaprakash Raichur
Published: (2020-07-01)